Эволюция лечения инфаркта миокарда за последние десятилетия. Значение работ Е.И. Чазова
Эволюция лечения инфаркта миокарда за последние десятилетия. Значение работ Е.И. Чазова
Шахнович Р.М., Руда М.Я. Эволюция лечения инфаркта миокарда за последние десятилетия. Значение работ Е.И. Чазова. Терапевтический архив. 2019; 91 (6): 25–33. DOI: 10.26442/00403660.2019.06.000291
________________________________________________
Shakhnovich R.M., Ruda M.Ya. The evolution of myocardial infarction treatment over the past decades. The significance of E.I. Chazov works. Therapeutic Archive. 2019; 91 (6): 25–33. DOI: 10.26442/00403660.2019.06.000291
Эволюция лечения инфаркта миокарда за последние десятилетия. Значение работ Е.И. Чазова
Шахнович Р.М., Руда М.Я. Эволюция лечения инфаркта миокарда за последние десятилетия. Значение работ Е.И. Чазова. Терапевтический архив. 2019; 91 (6): 25–33. DOI: 10.26442/00403660.2019.06.000291
________________________________________________
Shakhnovich R.M., Ruda M.Ya. The evolution of myocardial infarction treatment over the past decades. The significance of E.I. Chazov works. Therapeutic Archive. 2019; 91 (6): 25–33. DOI: 10.26442/00403660.2019.06.000291
Обзор представляет собой краткий исторический экскурс изучения инфаркта миокарда, в котором описаны основные открытия, сыгравшие важную роль в улучшении диагностики и лечения заболевания. Особое место в обзоре занимают работы выдающегося кардиолога и организатора здравоохранения Е.И. Чазова. Более полувека Евгений Иванович Чазов посвятил исследованию различных аспектов инфаркта миокарда, организовал систему медицинской помощи при инфаркте на всех этапах. Многие исследования Е.И. Чазова имеют мировое признание.
Ключевые слова: инфаркт миокарда, аортальная контрпульсация, палаты интенсивного наблюдения, острый коронарный синдром, Евгений Иванович Чазов.
________________________________________________
The review is a brief historical insight into the study of myocardial infarction, in which the main discoveries are analyzed that have played an important role in improving the diagnosis and treatment of the disease. A special place in the review is occupied by the work of the outstanding cardiologist and health care organizer E.I. Chazov. More than the half-age, E.I. Chazov investigated various aspects of myocardial infarction, organized a system of medical care for heart attack at all stages. Many studies E.I. Chazov are recognized worldwide.
1. Hammer A. Ein fall von thrombotischen verclusse einer der kranzarterien des herzens. Wiener Medizinsche Wochenschrift. 1878;28:97-102.
2. Стражеско Н.Д. Избранные труды. Киев: Издательство Академии наук Украинской ССР, 1957. 365 с. [Strazhesko ND. Izbrannye Trudy [Selected Works]. Kiev: Izdatel'stvo Akademii nauk Ukrainskoi SSR, 1957. 365 p. (In Russ.)].
3. Obrastzov WP, Strazhesko ND. Zur Kenntnis der Thrombose der Koronararterien des Herzens. Z Klin Med. 1910;71:116-32.
4. Pardee HEB. An electrocardiographic sign of coronary artery obstruction. Arch Int Med. 1920;26:244-57.
5. Einthoven W. Le télécardiogramme. Arch Int Physiol (Paris). 1906;4:132-64.
6. Wroblewski F, Karmen A, Ladue J. Serum Transaminase levels in experimental myocardial infarction. Circulation. 1955;11:711.
7. Thygesen K, Allan J, Bernard J, et al. Fourth universal definition of myocardial infarction (2018). Scientific Document Group. Eur Heart J. 2019;40(3):237-69. doi: 10.1093/eurheartj/ehy462
8. Beck CF, Weckesser EC, Barry FM. Fatal heart attack and successful defibrillation: new concepts in coronary artery disease. JAMA. 1956;161:434-6. doi: 10.1001/jama.1956.62970050001008
9. Julian DG. Treatment of cardiac arrest in acute myocardial ischaemia and infarction. Lancet. 1961; Oct 14;2(7207):840-4. doi: 10.1016/S0140-6736(61)90738-3
10. Brown KWG, MacMillan RL, Forbath N, et al. Coronary unit. An intensive care centre for acute myocardial infarction. Lancet. 1963;ii:349-52. doi: 10.1016/S0140-6736(63)93011-3
11. Чазов Е.И., Гольдберг Н.А. Прогностическое значение нарушений ритма и проводимости при остром инфаркте миокарда. Терапевтический архив. 1969;(4):57-62 [Chazov EI, Gol'dberg NA. The prognostic value of rhythm disturbances and conduction in acute myocardial infarction. Therapeutic Archive. 1969;(4):57-62 (In Russ.)].
12. Чазов Е.И., ред. Инфаркт миокарда: Монография. М.: Медицина, 1971. 311 с. [Chazov EI, ed. Infarkt miokarda: Monografiya [Myocardial Infarction: Monograph]. Moscow: Meditsina, 1971. 311 p. (In Russ.)].
13. Чазов Е.И., Николаева Л.Ф., Руда М.Я. Некоторые новые аспекты лечения больных острым инфарктом миокарда. Кардиология. 1977;(2):5-11 [Chazov EI, Nikolaeva LF, Ruda MYa. Some new aspects of the treatment of patients with acute myocardial infarction. Kardiologiya. 1977;(2):5-11 (In Russ.)].
14. Boersma E, Maas ACP, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour. Lancet. 1996;348:771. doi: 10.1016/S0140-6736(96)02514-7
15. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303:897-902. doi: 10.1056/NEJM198010163031601
16. Fletcher AP, Alkjaersig N, Smyrniotis FE. Treatment of patients suffering from early, myocardial infarction with massive and prolonged Streptokinase therapy. Trans Assoc Am Phys. 1958;71:287-96.
17. Yusuf S, Collins R, Peto R, et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J. 1985;6:556-85. doi: 10.1093/oxfordjournals.eurheartj.a061905
18. Чазов Е.И., Андреенко Г.В. Первый опыт терапии тромбоза отечественным фибринолизином. Кардиология. 1962;(4):59-63 [Chazov EI, Andreenko GV. The first experience of thrombosis therapy with domestic fibrinolysin. Kardiologiya. 1962;(4):59-63 (In Russ.)].
19. Чазов Е.И., Матвеева Л.С., Мазаев А.В. и др. Внутрикоронарное назначение фибринолизина при остром инфаркте миокарда. Терапевтический архив. 1976;48(4):8-17 [Chazov EI, Matveeva LS, Mazaev AV, et al. Intracoronary fibrinolysin administration in acute myocardial infarction. Therapeutic Archive. 1976;48(4):8-17 (In Russ.)].
20. Borja I, Stefan J, Stefan A, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J. 2017;00:1-66. doi: 10.1093/eurheartj/ehx393
21. Julian DG. The history of coronary care units. Br Heart J. 2018;39:119-77. doi: 10.1093/eurheartj/ehx393
22. Чазов Е.И. Инфаркт миокарда – прошлое, настоящее и некоторые проблемы будущего. Сердце. 2002;(1):6-9 [Chazov EI. Myocardial infarction – past, present and some problems of the future. Serdtse. 2002;(1):6-9 (In Russ.)].
23. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. The European Myocardial Infarction Project Group. N Engl J Med. 1993;329:383. doi: 10.1056/NEJM199308053290602
24. Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978;(1):263. doi: 10.1016/S0140-6736(78)90500-7
25. Hartzler GO, Rutherford BD, McConahay DR, et al. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J. 1983;106:965-73. doi: 10.1016/0002-8703(83)90639-7
26. Mehta RH, Harjai KJ, Cox D, et al. Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol. 2003;42:1739.
27. The GUSTO Investigators. The effects of tissue plasminogen activator, STreptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993;329:1615. doi: 10.1016/j.jacc.2003.07.012
28. Чазов Е.И., Трубецкой А.В., Руда М.Я. Опыт экспериментального применения противопульсации. Кардиология. 1966;(2):38 [Chazov EI, Trubetskoi AV, Ruda MYa. Experimental use of antipulsation. Kardiologiya. 1966;(2):38 (In Russ.)].
29. Hochman JS, Sleeper LA, Webb JG, et al. for the SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341:625. doi: 10.1056/NEJM199908263410901
30. Dzavik V, Sleeper LA, Cocke TP. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J. 2003;24:828. doi: 10.1016/s0195-668x(02)00844-8
31. Hochman JS. One-year survival following early revascularization for cardiogenic shock. JAMA. 2001;285:190. doi: 10.1001/jama.285.2.190
32. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006;295:2511. doi: 10.1001/jama.295.21.2511
33. Neumann F, Sousa-Uva M, Ahlsson A et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019 Jan 01;40(2):87-165. doi: 10.1093/eurheartj/ehy394
________________________________________________
1. Hammer A. Ein fall von thrombotischen verclusse einer der kranzarterien des herzens. Wiener Medizinsche Wochenschrift. 1878;28:97-102.
2. Стражеско Н.Д. Избранные труды. Киев: Издательство Академии наук Украинской ССР, 1957. 365 с. [Strazhesko ND. Izbrannye Trudy [Selected Works]. Kiev: Izdatel'stvo Akademii nauk Ukrainskoi SSR, 1957. 365 p. (In Russ.)].
3. Obrastzov WP, Strazhesko ND. Zur Kenntnis der Thrombose der Koronararterien des Herzens. Z Klin Med. 1910;71:116-32.
4. Pardee HEB. An electrocardiographic sign of coronary artery obstruction. Arch Int Med. 1920;26:244-57.
5. Einthoven W. Le télécardiogramme. Arch Int Physiol (Paris). 1906;4:132-64.
6. Wroblewski F, Karmen A, Ladue J. Serum Transaminase levels in experimental myocardial infarction. Circulation. 1955;11:711.
7. Thygesen K, Allan J, Bernard J, et al. Fourth universal definition of myocardial infarction (2018). Scientific Document Group. Eur Heart J. 2019;40(3):237-69. doi: 10.1093/eurheartj/ehy462
8. Beck CF, Weckesser EC, Barry FM. Fatal heart attack and successful defibrillation: new concepts in coronary artery disease. JAMA. 1956;161:434-6. doi: 10.1001/jama.1956.62970050001008
9. Julian DG. Treatment of cardiac arrest in acute myocardial ischaemia and infarction. Lancet. 1961; Oct 14;2(7207):840-4. doi: 10.1016/S0140-6736(61)90738-3
10. Brown KWG, MacMillan RL, Forbath N, et al. Coronary unit. An intensive care centre for acute myocardial infarction. Lancet. 1963;ii:349-52. doi: 10.1016/S0140-6736(63)93011-3
11. Chazov EI, Gol'dberg NA. The prognostic value of rhythm disturbances and conduction in acute myocardial infarction. Therapeutic Archive. 1969;(4):57-62 (In Russ.)
12. Chazov EI, ed. Infarkt miokarda: Monografiya [Myocardial Infarction: Monograph]. Moscow: Meditsina, 1971. 311 p. (In Russ.)
13. Chazov EI, Nikolaeva LF, Ruda MYa. Some new aspects of the treatment of patients with acute myocardial infarction. Kardiologiya. 1977;(2):5-11 (In Russ.)
14. Boersma E, Maas ACP, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour. Lancet. 1996;348:771. doi: 10.1016/S0140-6736(96)02514-7
15. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303:897-902. doi: 10.1056/NEJM198010163031601
16. Fletcher AP, Alkjaersig N, Smyrniotis FE. Treatment of patients suffering from early, myocardial infarction with massive and prolonged Streptokinase therapy. Trans Assoc Am Phys. 1958;71:287-96.
17. Yusuf S, Collins R, Peto R, et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J. 1985;6:556-85. doi: 10.1093/oxfordjournals.eurheartj.a061905
18. Chazov EI, Andreenko GV. The first experience of thrombosis therapy with domestic fibrinolysin. Kardiologiya. 1962;(4):59-63 (In Russ.)
19. Chazov EI, Matveeva LS, Mazaev AV, et al. Intracoronary fibrinolysin administration in acute myocardial infarction. Therapeutic Archive. 1976;48(4):8-17 (In Russ.)
20. Borja I, Stefan J, Stefan A, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J. 2017;00:1-66. doi: 10.1093/eurheartj/ehx393
21. Julian DG. The history of coronary care units. Br Heart J. 2018;39:119-77. doi: 10.1093/eurheartj/ehx393
22. Chazov EI. Myocardial infarction – past, present and some problems of the future. Serdtse. 2002;(1):6-9 (In Russ.)
23. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. The European Myocardial Infarction Project Group. N Engl J Med. 1993;329:383. doi: 10.1056/NEJM199308053290602
24. Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978;(1):263. doi: 10.1016/S0140-6736(78)90500-7
25. Hartzler GO, Rutherford BD, McConahay DR, et al. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J. 1983;106:965-73. doi: 10.1016/0002-8703(83)90639-7
26. Mehta RH, Harjai KJ, Cox D, et al. Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol. 2003;42:1739.
27. The GUSTO Investigators. The effects of tissue plasminogen activator, STreptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993;329:1615. doi: 10.1016/j.jacc.2003.07.012
28. Chazov EI, Trubetskoi AV, Ruda MYa. Experimental use of antipulsation. Kardiologiya. 1966;(2):38 (In Russ.)
29. Hochman JS, Sleeper LA, Webb JG, et al. for the SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341:625. doi: 10.1056/NEJM199908263410901
30. Dzavik V, Sleeper LA, Cocke TP. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J. 2003;24:828. doi: 10.1016/s0195-668x(02)00844-8
31. Hochman JS. One-year survival following early revascularization for cardiogenic shock. JAMA. 2001;285:190. doi: 10.1001/jama.285.2.190
32. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006;295:2511. doi: 10.1001/jama.295.21.2511
33. Neumann F, Sousa-Uva M, Ahlsson A et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019 Jan 01;40(2):87-165. doi: 10.1093/eurheartj/ehy394
Авторы
Р.М. Шахнович, М.Я. Руда
ФГБУ «Национальный медицинский исследовательский центр кардиологии» Минздрава России, Москва, Россия
________________________________________________
R.M. Shakhnovich, M.Ya. Ruda
National Medical Research Center of Cardiology, Moscow, Russia